alpha-hydroxymetoprolol has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, HW; Li, SS; Liu, YJ; Su, ZY; Wu, HL; Yin, XL; Yu, RQ | 1 |
| Ismail, R; Teh, LK | 1 |
1 trial(s) available for alpha-hydroxymetoprolol and Cardiovascular Diseases
| Article | Year |
|---|---|
The relevance of CYP2D6 genetic polymorphism on chronic metoprolol therapy in cardiovascular patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiovascular Diseases; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Kidney Diseases; Male; Metoprolol; Middle Aged; Pharmacogenetics; Polymorphism, Genetic | 2006 |
1 other study(ies) available for alpha-hydroxymetoprolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Simultaneous determination of metoprolol and α-hydroxymetoprolol in human plasma using excitation-emission matrix fluorescence coupled with second-order calibration methods.
Topics: Adrenergic beta-1 Receptor Antagonists; Algorithms; Blood Chemical Analysis; Calibration; Cardiovascular Diseases; Humans; Kinetics; Metoprolol; Oxidation-Reduction; Spectrometry, Fluorescence | 2012 |